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Background: Non malignant invasive tumors of the colon and rectum are very rare. Gastrointestinal Basidiobolomycosis
can present as a mass lesion mimicking colorectal cancer.
Case presentation: A 56 year old Caucasian male was evaluated for abdominal and pelvic pain for 4 weeks complicated
by acute urinary retention. Radiological evaluation showed him to have recto-sigmoid and cecal mass. Endoscopic
examination and biopsies did not reveal a definite diagnosis. Computerized tomography guided biopsy of the mass
showed fungal elements consistent with gastrointestinal basidiobolomycosis. He was treated with Itraconazole for 12
months with very good clinical and radiological response.
Conclusion: Basidiobolomycosis of the gastrointestinal tract should be considered during evaluation of colorectal masses
with atypical presentation. It is a rare entity seen more in endemic regions of the world for basidiobolomycosis including
southwestern United States.
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Rapidly progressing infiltrative lesions of colon and rectum
are malignant unless proved otherwise. Benign invasive tu-
mors of the colon and rectum are very uncommon. Gastro-
intestinal Basidiobolomycosis (GIB) should be considered
when clinical suspicion for non malignant causes for colo-
rectal tumors are being sought. Basidiobolomycosis is a rare
but emerging cause of abdominal pain, rectal pain, and ab-
dominal mass that is being increasingly recognized in the
literature as a potential mimicker of gastrointestinal malig-
nancy. It is caused by Basidiobolus ranarum, a saprophytic
fungus found in the environment worldwide. Review of lit-
erature over the last two decades shows increasing reports
on gastrointestinal basidiobolomycosis in immunocompe-
tent individuals in arid regions of the world, particularly in
the southwestern United States and the Middle East. We
report a patient with obstructing rectal and cecal mass from
invasive basidiobolomycosis which was treated without sur-
gery. This case report and literature review would increase
the awareness of GIB which is a serious but completely cur-
able condition.* Correspondence: driyoob@email.arizona.edu
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A 56 year old Caucasian male with history of non insulin
dependent diabetes presented with lower abdominal pain
with increasing frequency of bowel movements for 3
months, rectal pain for a month and acute onset urinary
retention. He also reported sporadic night sweats and
subjective fever for 5 months. Earlier work up by his
primary physician failed to elucidate a cause for his
symptoms. On presentation, he was afebrile and remained
hemodynamically stable. His physical examination showed
right lower quadrant tenderness with no signs of peritonitis.
Digital rectal examination showed tender, firm nodular
mass along the anterior wall of rectum. Laboratory results
revealed leukocytosis with neutrophilia and eosinophilia.
Radiological examination included Computed Tomography
(CT) scan and Magnetic Resonance Imaging (MRI) scan of
abdomen and pelvis. They demonstrated circumferential
thickening of recto sigmoid region measuring 16 cm in
length with significant luminal narrowing (Figure 1). There
was an extrinsic component to the lesion with extension
anteriorly into seminal vesicles and prostate and posteriorly
into the presacral region.
He had another inflammatory lesion involving the cecum
circumferentially and measuring 6 cm in length was alsod Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Magnetic Resonance Imaging scan showing circumferential thickening of cecum and rectum pre treatment.
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appendix and the mesentery. He had significant retroperi-
toneal lymphadenopathy involving the external iliac, com-
mon iliac and para-aortic nodes.
Patient’s social history was significant for his residence
in southern Arizona for the last 28 years.
He is a professor of archaeology and geography with
extensive travel history to the Middle East including
Jordan and Israel. Incidentally he had installed a sprinkler
system at his property a month prior to the onset of his
symptoms. He had an earlier screening colonoscopy show-
ing sigmoid diverticulosis 2 years ago. Differential diagno-
sis considered at this point included colorectal cancer and
lymphoma.
Endoscopic examination showed congested circumfer-
ential lesion from anal verge to up to 27 cm proximal to
anus (Figure 2). Histopathological examination of biopsies
showed marked mucosal eosinophilia without an associ-
ated increase in mast cells and failed to reveal a specific
diagnosis. Endoscopic examination and biopsies were re-
peated with no additional benefit. CT guided biopsy of the
lesion was performed to obtain additional specimens from
extrinsic component of the lesion over the cecum and
recto-sigmoid lesion. Histopathological examination of CT
guided biopsy showed granulation tissue with extensiveFigure 2 Endoscopic examination of rectosigmoid region showing coacute inflammation and fibrosis along with fungal organ-
isms which were confirmed by Grocott's methenamine sil-
ver (GMS) stain. The morphology of the fungal organisms
on the staining within the clinical context were consistent
with basidiobolomycosis (Figure 3). No associated malig-
nancy was identified.
The patient was treated for basidiobolomycosis with
oral itraconazole therapy (100 mg oral twice daily) with
significant improvement in pain, frequency of stools and
urinary retention within 4 days. His anti fungal treat-
ment was continued over the next 12 months with peri-
odic clinical and radiological examinations. Although no
specific guidelines are available on the duration of the
treatment and surveillance for treatment response, we
chose to evaluate him with MRI scans at 3 month inter-
vals to evaluate the response to antifungal treatment. He
continue to improve symptomatically with near reso-
lution of the lesion on the MRI scan of pelvis after 12
months of treatment (Figure 4).
Conclusions
Non malignant invasive tumors of the colon and rectum
are very rarely seen in clinical practice. More than 95%
of all invasive tumors of the colon and rectum are
adenocarcinomas. Atypical presentation of lesions in thengested, friable lesion.
Figure 3 Papanicolaou stain of rectal mass fine needle aspiration cytology with arrows showing broad non septated fungal organism
surrounded by acute inflammation.
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oid tumors, sarcomas and lymphomas. Basidiobolomyco-
sis of the gastrointestinal tract should be considered when
both carcinomas, sarcomas and lymphoma are ruled out
and other causes are being considered. It should be within
the list of differential diagnosis while evaluating patients
with small bowel, colonic and rectal masses of unclear ori-
gin particularly in endemic regions of basidiobolomycosis
including southwestern United States.
Basidiobolomycosis is caused by Basidiobolus ranarum,
a saprophytic fungus found in the environment worldwide.
It is a member of the order Entomophthorales of the class
Zygomycetes [1,2]. Clinical spectrum of diseases from
Basidiobolomycosis usually include skin and subcutaneous
lesions presenting as indurated lesions affecting extrem-
ities, trunk and gluteal region only [3,4]. Inoculation from
minor trauma or insect bites appear to be the mode of ac-
quisition of the fungus [5-7]. Unintentional ingestion of
the fungus from contaminated soil or fruits or vegetables
is touted as the route of entry preceding GIB. Although
living in tropical and subtropical areas are well established
as risk factors for basidiobolomycosis, no risk factors are
identifiable for GI basidiobolomycosis per se. Incidentally,
basidiobolomycosis affects men more likely due to theirFigure 4 Magnetic Resonance Imaging scan showing near resolution of
antifungal therapy.indulgence in outdoor activity compared to women in the
tropics.
Literature review by Vikram et al. [8] showed 44 cases
of GIB in the previous 30 years [8]. Most of the cases re-
ported are from Arizona and Saudi Arabia. Most of these
patients were diagnosed with abdominal mass on CT scan
and endoscopy after having been evaluated for indolent
non specific signs and symptoms. Patients were normally
immunocompetent men with no underlying serious med-
ical problems. Routine laboratory work up showed periph-
eral eosinophilia. Diagnosis were confirmed by culture of
tissue specimens. GIB involved colon (82%); small bowel
(36%) and liver and gallbladder (30%). 84% patients under-
went surgical excision of the masses and were treated with
antifungal agents. 80% of patients survived following the
above management.
There have been 17 previous reports of GIB from
Arizona since 1997. Two other cases have been re-
ported from Utah and Florida [9]. Case control study
conducted by Center for Disease Control and Preven-
tion (CDC) showed the following potential risk factors
for GIB: Prolonged residence in Arizona, prior treat-
ment of peptic ulcer disease, diabetes, outdoor activ-
ities including gardening and landscaping [10].the circumferential thickening of cecum and rectum after 1 year of
Mohammed Ilyas et al. BMC Research Notes  (2015) 8:32 Page 4 of 5Case series by Saud Al Shanafey reported 9 pediatric
cases of GIB at King Faisal Specialist Hospital and re-
search center between 2001 and 2010 [11]. Distribution
of lesions included left colon involvement in 11%, right
colonic involvement in 33%, liver involvement in 78%
and diffuse abdominal disease in 22%. Patients with co-
lonic involvement in GIB had right or left hemicolectomy.
Liver lesions were managed with partial hepatectomy. One
patient who had multiple smaller lesions in both lobe of
the liver was treated with antifungal medications success-
fully. It is interesting to note that 89% of the patients were
of male gender. These patients had a median workup for 4
months before being diagnosed with GIB. Clinical presen-
tation generally included vague abdominal pain, fever,
change in bowel habits, weight loss and palpable abdominal
mass. Tests showed patients to have leukocytosis, eosino-
philia, raised ESR and CRP. Two patients had disseminated
abdominal disease and died despite aggressive management.
All the surviving patients were treated with long term anti-
fungal medications. Pediatric GIB has also been reported by
Al Jarie et al. and others [12-14].
Management of GIB depends on the clinical presentations.
Patients who present with complete bowel obstruction would
need emergent surgery to relieve the obstruction. Failure to
identify and appropriately treat this rare diagnosis has been
complicated by acute colonic obstruction necessitating
emergency colostomy [13] and mortality [15]. Sub acute
to chronic presentations (as in our patient) could be man-
aged electively. Although Saud Al Shanafey et al. proposed
early surgical intervention in patients with GIB to avoid
morbidity and mortality, it may not be necessary when the
presentation is rather less emergent. Anti fungal treatment
alone may be sufficient to eradicate the lesion (as in our
patient), but it would depend on the clinical presentation
and the response of the lesion to antifungal treatment. If
surgery is required, conservative resection to reduce the
bulk of the lesion and to maintain GI and biliary continu-
ity would be sufficient. This has been reported to improve
response to medical management. Close follow up is rec-
ommended in the postoperative period to ensure eradica-
tion of the disease. Investigations during the follow up
period would depend on the mode of presentation and the
site of the lesion. Response to medical treatment of lesions
involving the cecum, ascending colon and recto-sigmoid re-
gion can be evaluated with MRI of abdomen and pelvis.
Duration of treatment has not been standardized. Most
of the patients have been treated with antifungal treatment
ranging from 6 months to 1 year. Vikram et al. reported
relapse with discontinuation of treatment after 3 months
based on symptomatic improvement.
Diagnosis of basidiobolomycosis require culture of B
ranarum from the tissue specimen. But, presumptive diag-
nosis could be made from the histopathological appearance.
Microscopic appearance of B ranarum include scarce,broad and thin walled pleomorphic hyphae surrounded by
collar of eosinophilic material known as Splendorehoeppli
phenomenon [16]. Susceptibility of Basidiobolomycosis to
antifungal agents are known to be highly variable and iso-
late dependent [17,18]. Empiric treatment could be started
with Itraconazole or Voriconazole, but susceptibility testing
is recommended to ensure effective treatment. Taghipour
et al. reported a mortality with GIB from septic shock and
pulmonary insufficiency despite successful diagnosis and
treatment with Itraconazole and amphotericin B. Surveil-
lance of treatment response could be performed with MRI
or CT scans. There are no consensus opinion on the im-
aging modality and duration of surveillance in the litera-
ture. We propose the surveillance imaging could be
performed with CT scan or MRI scans depending on the
local availability and expertise.
In summary, GIB is a rare invasive fungal infection in-
volving the gastrointestinal tract and liver. If identified
early and treated appropriately, it is curable and surgery
can be avoided. Surgery is unavoidable if GIB is compli-
cated by bowel obstruction. Awareness and knowledge is
important for early diagnosis and treatment of GIB and
prevent morbidity and mortality from delay in diagnosis.
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